BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27492695)

  • 1. Lactobacillus crispatus as biomarker of the healthy vaginal tract.
    Lepargneur JP
    Ann Biol Clin (Paris); 2016 Aug; 74(4):421-7. PubMed ID: 27492695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
    Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
    Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytokine and metabolite production by cervicovaginal epithelial cells infected with Lactobacillus crispatus and Ureaplasma urealyticum.
    Cavanagh M; Amabebe E; Anumba DOC
    Anaerobe; 2020 Apr; 62():102101. PubMed ID: 31525453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.
    Nardini P; Ñahui Palomino RA; Parolin C; Laghi L; Foschi C; Cevenini R; Vitali B; Marangoni A
    Sci Rep; 2016 Jun; 6():29024. PubMed ID: 27354249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defence factors of vaginal lactobacilli.
    Kovachev S
    Crit Rev Microbiol; 2018 Feb; 44(1):31-39. PubMed ID: 28418713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Lactobacillus crispatus isolated from vaginal microbiota against Mycobacterium tuberculosis.
    Lee Y; Seo H; Kim S; Rahim MDA; Yoon Y; Jung J; Lee S; Beom Ryu C; Song HY
    J Microbiol; 2021 Nov; 59(11):1019-1030. PubMed ID: 34724180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug.
    Lagenaur LA; Hemmerling A; Chiu C; Miller S; Lee PP; Cohen CR; Parks TP
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S296-S306. PubMed ID: 33330916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
    Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
    Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate.
    Ahire JJ; Sahoo S; Kashikar MS; Heerekar A; Lakshmi SG; Madempudi RS
    Probiotics Antimicrob Proteins; 2023 Apr; 15(2):275-286. PubMed ID: 34417721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
    O'Hanlon DE; Moench TR; Cone RA
    PLoS One; 2013; 8(11):e80074. PubMed ID: 24223212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells:
    Song J; Lang F; Zhao N; Guo Y; Zhang H
    Front Immunol; 2018; 9():2437. PubMed ID: 30410487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Comparisons of Lactobacillus crispatus and Lactobacillus iners Reveal Potential Ecological Drivers of Community Composition in the Vagina.
    France MT; Mendes-Soares H; Forney LJ
    Appl Environ Microbiol; 2016 Dec; 82(24):7063-7073. PubMed ID: 27694231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some probiotic properties of vaginal lactobacilli isolated from healthy women.
    Aslim B; Kilic E
    Jpn J Infect Dis; 2006 Aug; 59(4):249-53. PubMed ID: 16936344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 17β-estradiol on a human vaginal Lactobacillus crispatus strain.
    Clabaut M; Suet A; Racine PJ; Tahrioui A; Verdon J; Barreau M; Maillot O; Le Tirant A; Karsybayeva M; Kremser C; Redziniak G; Duclairoir-Poc C; Pichon C; Chevalier S; Feuilloley MGJ
    Sci Rep; 2021 Mar; 11(1):7133. PubMed ID: 33785829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota.
    van der Veer C; Hertzberger RY; Bruisten SM; Tytgat HLP; Swanenburg J; de Kat Angelino-Bart A; Schuren F; Molenaar D; Reid G; de Vries H; Kort R
    Microbiome; 2019 Mar; 7(1):49. PubMed ID: 30925932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into phenotypic and genotypic differences between vaginal
    Costantini PE; Firrincieli A; Fedi S; Parolin C; Viti C; Cappelletti M; Vitali B
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34096840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of Epithelial Cells and Vaginal Secretions in Pregnant Women When Lactobacillus crispatus or Lactobacillus iners Dominate the Vaginal Microbiome.
    Leizer J; Nasioudis D; Forney LJ; Schneider GM; Gliniewicz K; Boester A; Witkin SS
    Reprod Sci; 2018 Jun; 25(6):854-860. PubMed ID: 28301987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S; Silva J; Teixeira P
    Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstrain Variability of Human Vaginal
    Puebla-Barragan S; Watson E; van der Veer C; Chmiel JA; Carr C; Burton JP; Sumarah M; Kort R; Reid G
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.